| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.6M | +316.3% |
| R&D Expense | $89.1M | +8.4% |
| SG&A Expense | $48.8M | +18.1% |
| Operating Income | -$101.4M | +11.7% |
| Interest Expense | $26K | -46.9% |
| Net Income | -$89.0M | +15.0% |
| EPS (Basic) | -$1.65 | +30.7% |
| EPS (Diluted) | -$1.65 | +30.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.0M | -33.1% |
| Current Assets | $232.8M | +8.1% |
| Total Assets | $271.6M | +18.9% |
| Current Liabilities | $40.1M | +30.0% |
| Total Liabilities | $42.5M | -38.2% |
| Stockholders' Equity | $229.0M | +43.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$86.9M | -7.1% |
| Capital Expenditures | $203K | -87.4% |
| Investing Cash Flow | -$107.5M | -201.4% |
| Financing Cash Flow | $131.1M | +147.3% |
| Free Cash Flow | -$87.1M | -5.3% |